Malignant Melanoma Completed Phase 1 / 2 Trials for Paclitaxel (DB01229)

Also known as: Melanoma, Malignant / [M]Malignant melanoma NOS (morphologic abnormality) / Melanoma / Malignant melanoma (morphologic abnormality) / Malignant melanoma (disorder) / [M]Malignant melanoma NOS or melanocarcinoma or melanoma NOS / Melanoma: [skin] or [malignant] / Melanoma malignant

IndicationStatusPhase
DBCOND0029825 (Malignant Melanoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01962103Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid TumorsTreatment